BioTuesdays

BTIG launched coverage of Definitive Healthcare (NASDAQ:DH) with a “buy” rating and $7 target price. The stock closed at $4.44 on September 16.

Senseonics, Incorporated (NYSE:SENS) and closely-held Ascensia Diabetes Care herald a significant breakthrough in diabetes technology and management, announcing FDA approval of Eversense 365, the world’s first one-year continuous glucose monitoring (CGM) system with a 365-day sensor for adults aged 18 and over with Type 1 and Type 2 diabetes.

Closely-held PharmaJet has announced a strategic partnership with Scancell Ltd (AIM:SCLP) to supply its Stratis Intramuscular (IM) Needle-free Injection System for delivery of Scancell’s advanced melanoma DNA vaccine (Immunobody SCIB1/SCIB1+) for both clinical development and commercial use.

Closely-held Ripple Therapeutics has entered into a collaboration and option-to-lease agreement with AbbeVie (NYSE:ABBV) to develop RTC-620, a next generation, fully biodegradable, sustained-release drug delivery intracameral implant with repeat dosing capabilities, aimed at reducing intraocular pressure (IOP) inpatients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

🌟 Feature Article 🌟 InfoBionic.Ai is raising the bar in remote cardiac care with its MoMe Arc platform, combining AI-powered telemetry and continuous monitoring to improve patient outcomes. In our latest #BioTuesdays feature, CEO Stuart Long discusses how their advanced AI-driven solutions are revolutionizing cardiac diagnostics and patient care. 🔗https://lnkd.in/gNhgdqcD Kilmer Lucas Inc.

Profound Medical Inc. (NASDAQ:PROF; TSX:PRN) hosted its second PRO-Talk Live! educational event, by physicians for physicians, in Las Vegas this past weekend. The event featured a prestigious panel of experts, innovators, and guest speakers including global medtech leaders, Siemens Healthineers and Cook Medical.

Inspira Technologies (NASDAQ:IINN) has announced the approval of a second U.S. patent for VORTEX, its orbiting blood oxygenation delivery system designed to oxygenate blood without the use of fibre membranes, bringing the total number of patents for this technology to 32. https://lnkd.in/gEXaNbVg

Evaxion Biotech A/S (NASDAQ:EVAX) has announced positive one-year data from its Phase 2 trial of the AI-designed personalized cancer vaccine, EVX-01, a potential treatment for melanoma.

Cidara Therapeutics (NASDAQ:CDTX) has announced a planned workforce reduction, impacting approximately 30% of the company’s employees, enabling the company to reduce capital needs and concentrate on the clinical development of CD388, a novel DFC candidate for influenza A and B.

Tenon Medical, Inc. (NASDAQ:TNON) announced the limited alpha launch of its new Catamaran SE SI Joint Fusion System in early Q4. The company aims to gather initial user feedback from a select group of physicians to support a broader launch in the coming months.